抗菌薬感受性試験の世界市場の評価：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

世界の抗菌薬感受性試験（AST）の市場規模は、予測期間の2024年～2031年に6.07%のCAGRで拡大し、2023年の40億1,000万米ドルから2031年には64億3,000万米ドルに成長すると予測されています。抗菌薬感受性試験市場は臨床診断産業の重要な一部であり、ヘルスケア産業で最も速い成長率を占めています。市場を牽引している要因は、感染症の流行、微生物耐性の上昇、技術の進歩、政府の取り組みなどです。

臨床検査室では、抗菌薬感受性試験（AST）は、病気の原因となっている特定の微生物に対して、どの抗生物質やその他の抗菌薬が有効で、どの程度の量を投与すれば効果が期待できるかを特定するために使用されます。これらの検査は、抗菌薬感受性試験に使用されるさまざまな医療機器の助けを借りて行われます。FDAの機器・放射線衛生センター（CDRH）は、AST機器を米国で販売する前に、臨床検査室で使用するための検査と承認を行わなければなりません。従来のASTに加えて、抗生物質に耐性を持つ細菌に関連する遺伝子情報、あるいは耐性指標を同定するための迅速診断検査が数多く利用可能です。CDRHは、微生物が時間の経過とともに適応し、薬に反応しなくなることを抗菌薬耐性、あるいは抗菌薬耐性（AMR）と呼ぶ場合に、これらの検査を検討し、承認しています。米国疾病予防管理センター（CDC）は、毎年35,000人以上が抗菌薬耐性の病気で命を落としており、米国では毎年少なくとも280万人が感染していると推定しています。

感染症の罹患率の上昇は、抗菌薬感受性試験市場の需要を促進する主な要因の1つです。世界中で細菌、真菌、ウイルスによる感染症が増加しているため、抗生物質によるより効果的な治療が必要となっています。これらの疾患の特定と治療は、異なる種類の病原体が異なる種類の抗生物質にどのように反応するかを示すASTに大きく依存しています。抗生物質感受性検査は、医師が適切な抗菌薬療法を特定することによって効果的な治療を処方するのに役立ち、その結果、抗菌薬に対する耐性の可能性を減らし、患者の転帰を改善します。感染症がより一般的になっているため、感染症に対する新しい診断検査の開発と配布により、迅速で正確なASTの需要が大幅に増加しています。

当レポートでは、世界の抗菌薬感受性試験市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の抗菌薬感受性試験市場の見通し、2017年～2031年

• 市場規模の分析と予測
• 市場シェア分析と予測
• 市場マップ分析、2023年
  • 製品別
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 北米の抗菌薬感受性試験市場の見通し、2017年～2031年

第6章 欧州の抗菌薬感受性試験市場の見通し、2017年～2031年

第7章 アジア太平洋の抗菌薬感受性試験市場の見通し、2017年～2031年

第8章 南米の抗菌薬感受性試験市場の見通し、2017年～2031年

第9章 中東・アフリカの抗菌薬感受性試験市場の見通し、2017年～2031年

第10章 需要供給分析

第11章 輸出入の分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

第17章 規制枠組みとイノベーション

第18章 市場の動向と発展

第19章 ケーススタディ

第20章 競合情勢

• 市場リーダートップの競合マトリックス
• 5参入企業トップのSWOT分析
• 市場の主要参入企業トップ10の情勢
  • Biomeriux SA
  • Bio-Rad Laboratories Inc
  • HiMedia Laboratories
  • Alifax S.r.l Italy
  • Becton Dickinson and Company
  • Creative Diagnostics
  • Resistell AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc
  • Merck KGaA

第21章 戦略的提言

第22章 お問い合わせと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 3. Global Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 4. Global Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 5. Global Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 6. Global Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 7. Global Antimicrobial Susceptibility Testing Market Share (%), By Region, 2017-2031F
• Figure 8. North America Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 9. North America Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 10. North America Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 11. North America Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 12. North America Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 13. North America Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 14. North America Antimicrobial Susceptibility Testing Market Share (%), By Country, 2017-2031F
• Figure 15. United States Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 16. United States Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 17. United States Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 18. United States Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 19. United States Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 20. United States Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 21. Canada Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 22. Canada Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 23. Canada Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 24. Canada Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 25. Canada Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 26. Canada Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 27. Mexico Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 28. Mexico Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 29. Mexico Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 30. Mexico Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 31. Mexico Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 32. Mexico Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 34. Europe Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 35. Europe Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 36. Europe Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 37. Europe Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 38. Europe Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 39. Europe Antimicrobial Susceptibility Testing Market Share (%), By Country, 2017-2031F
• Figure 40. Germany Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 41. Germany Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 42. Germany Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 43. Germany Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 44. Germany Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 45. Germany Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 46. France Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 47. France Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 48. France Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 49. France Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 50. France Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 51. France Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 52. Italy Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 53. Italy Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 54. Italy Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 55. Italy Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 56. Italy Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 57. Italy Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 58. United Kingdom Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 59. United Kingdom Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 60. United Kingdom Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 61. United Kingdom Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 62. United Kingdom Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 63. United Kingdom Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 64. Russia Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 65. Russia Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 66. Russia Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 67. Russia Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 68. Russia Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 69. Russia Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 70. Netherlands Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 71. Netherlands Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 72. Netherlands Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 73. Netherlands Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 74. Netherlands Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 75. Netherlands Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 76. Spain Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 77. Spain Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 78. Spain Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 79. Spain Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 80. Spain Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 81. Spain Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 82. Turkey Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 83. Turkey Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 84. Turkey Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 85. Turkey Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 86. Turkey Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 87. Turkey Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 88. Poland Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 89. Poland Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 90. Poland Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 91. Poland Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 92. Poland Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 93. Poland Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 94. South America Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 95. South America Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 96. South America Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 97. South America Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 98. South America Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 99. South America Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 100. South America Antimicrobial Susceptibility Testing Market Share (%), By Country, 2017-2031F
• Figure 101. Brazil Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 102. Brazil Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 103. Brazil Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 104. Brazil Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 105. Brazil Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 106. Brazil Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 107. Argentina Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 108. Argentina Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 109. Argentina Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 110. Argentina Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 111. Argentina Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 112. Argentina Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 113. Asia-Pacific Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 114. Asia-Pacific Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 115. Asia-Pacific Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 116. Asia-Pacific Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 117. Asia-Pacific Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 118. Asia-Pacific Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 119. Asia-Pacific Antimicrobial Susceptibility Testing Market Share (%), By Country, 2017-2031F
• Figure 120. India Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 121. India Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 122. India Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 123. India Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 124. India Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 125. India Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 126. China Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 127. China Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 128. China Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 129. China Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 130. China Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 131. China Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 132. Japan Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 133. Japan Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 134. Japan Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 135. Japan Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 136. Japan Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 137. Japan Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 138. Australia Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 139. Australia Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 140. Australia Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 141. Australia Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 142. Australia Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 143. Australia Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 144. Vietnam Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 145. Vietnam Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 146. Vietnam Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 147. Vietnam Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 148. Vietnam Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 149. Vietnam Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 150. South Korea Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 151. South Korea Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 152. South Korea Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 153. South Korea Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 154. South Korea Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 155. South Korea Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 156. Indonesia Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 157. Indonesia Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 158. Indonesia Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 159. Indonesia Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 160. Indonesia Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 161. Indonesia Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 162. Philippines Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 163. Philippines Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 164. Philippines Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 165. Philippines Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 166. Philippines Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 167. Philippines Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 168. Middle East & Africa Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 169. Middle East & Africa Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 170. Middle East & Africa Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 171. Middle East & Africa Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 172. Middle East & Africa Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 173. Middle East & Africa Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 174. Middle East & Africa Antimicrobial Susceptibility Testing Market Share (%), By Country, 2017-2031F
• Figure 175. Saudi Arabia Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 176. Saudi Arabia Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 177. Saudi Arabia Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 178. Saudi Arabia Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 179. Saudi Arabia Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 180. Saudi Arabia Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 181. UAE Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 182. UAE Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 183. UAE Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 184. UAE Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 185. UAE Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 186. UAE Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 187. South Africa Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2017-2031F
• Figure 188. South Africa Antimicrobial Susceptibility Testing Market, By Volume, In Million Units, 2017-2031F
• Figure 189. South Africa Antimicrobial Susceptibility Testing Market Share (%), By Product, 2017-2031F
• Figure 190. South Africa Antimicrobial Susceptibility Testing Market Share (%), By Type, 2017-2031F
• Figure 191. South Africa Antimicrobial Susceptibility Testing Market Share (%), By Application, 2017-2031F
• Figure 192. South Africa Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2017-2031F
• Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 194. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global antimicrobial susceptibility testing market is projected to witness a CAGR of 6.07% during the forecast period 2024-2031, growing from USD 4.01 billion in 2023 to USD 6.43 billion in 2031. The antimicrobial susceptibility testing market is an important part of clinical diagnostics industry, accounting for one of the fastest growth rates in the healthcare industry. Factors are driving the market such as growing prevalence of infectious diseases, rising microbial resistance, technological advancements, and government initiatives.

In clinical laboratories, antimicrobial susceptibility tests (ASTs) are used to identify which antibiotics or other antimicrobial medicines are expected to be successful against a certain microbe causing an illness and what dose is required to be effective. These tests are performed with the help of different medical devices used for antimicrobial susceptibility tests. The FDA's Center for Devices and Radiological Health (CDRH) must examine and approve any AST devices before they may be marketed in the United States for use in clinical labs. A number of fast diagnostic tests are available to identify genetic information, or resistance indicators linked to bacteria that are resistant to antibiotics, in addition to traditional ASTs. CDRH examines and approves these tests when microorganisms adapt over time and stop responding to medications, it's known as antimicrobial resistance, or antimicrobial resistance (AMR). The Centers for Disease Control and Prevention (CDC) estimate that over 35,000 individuals lose their lives to antimicrobial-resistant illnesses each year, which account for at least 2.8 million infections in the United States annually.

The UN views AMR as a worldwide threat and issues a warning by 2050, wherein drug-resistant illnesses might claim 10 million lives annually. Antimicrobial resistance may push up to 24 million people into severe poverty by 2030, according to the United Nations estimates.

Growing Prevalence of Infectious Diseases

The growing incidence of infectious diseases is one of the key factors driving the demand for antimicrobial susceptibility testing market. The increasing rate of infections caused by bacteria, fungi, and viruses around the world has necessitated more effective treatment through antibiotics. The identification and treatment of these diseases relies heavily on AST which shows how different types of pathogens response to different kinds of antibiotics. Antibiotic susceptibility testing helps doctors to prescribe effective treatments by identifying the right antimicrobial therapy, thus reducing the likelihood of resistance to antimicrobials, improving patient outcomes. Since infectious diseases are becoming more common, the demand for fast and accurate ASTs has increased significantly due to the development and distribution of new diagnostic tests for infectious diseases.

As per HIV.gov in 2022, there were more than 39 million patients globally. Out of which, 37.5 million were adults and 1.5 million were children. WHO estimates that close to 25% of the global population i.e 1.8 billion people have tuberculosis.

Government Initiatives to Support the Global AST Market

Government funding and government initiatives are playing an important role in supporting and increasing the adoption of antimicrobial susceptibility testing kits and devices. Regulatory agencies such as the FDA (Food and Drug Administration) in the United States have issued guidance and necessary steps to help animal drugs sponsors establish defined duration of use for certain medically important antimicrobial drugs, supporting the appropriate drug usage and growing need for antimicrobial susceptibility testing. Additionally, the FDA has funded R&D initiatives through programs such as Broad Agency Announcement for supporting regulatory science and innovation in antimicrobial resistance. Government-funded partnerships, such as CARB-X, provide funding and support for early-stage projects focused towards new antibiotics, diagnostics, and other technologies to fight against drug-resistant bacteria. In March 2024, CARB-X announced its 100th project funding for addressing antibiotic resistance. CARB-X granted USD 1.06 million to Germany-based company named HIPS for the development of new class of small-molecule inhibitors.

Drug Discovery and Development is Expected to Grow at the Fastest Rate in the Forecast Period

Drug discovery and development will grow at a fast pace in the upcoming years in the global antimicrobial susceptibility testing market. Testing the antibiotic susceptibility of notable bacterial isolates is an essential function of the clinical microbiology lab. Testing ensures the susceptibility of the recommended medication for a disease and the identification of potential drug resistance in living organisms. Once the bacteria or fungi causing an individual's infection are collected in the sample culture, the susceptibility testing is carried upon it. Drug susceptibility testing can be carried out utilizing nucleic acid-based techniques, semiquantitative approaches, or qualitative methods.

At ESCMID 2024 (European Society of Clinical Microbiology and Infectious Disease), several advancements in drug resistance testing were announced, such as rapid nanomotion-based susceptibility testing and MALDI-TOF-MS could be used to identify resistance mechanisms of several deadly organisms. The conference discussed different types of novel resistance testing technologies such as machine learning models, and matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

North America Dominates the Global Antimicrobial Susceptibility Testing Market

North America dominated the share of the global antimicrobial susceptibility testing market in 2023, and is expected to maintain the dominance in the forecast period. High prevalence of infectious diseases and growing burden of antibiotic resistance in countries such as the United States, Canada, and Mexico are some major drivers. The United States and Canada have advanced healthcare technologies and infrastructure couple with high healthcare spending and priority towards extensive research and development, which is facilitating the adoption of advanced antimicrobial susceptibility testing technologies. In February 2024, Visby Medical received a grant of USD 1.8 million to develop a fast and portable gonorrhoea diagnosis test that includes testing for antibiotic susceptibility. Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a US-based non-profit organization granted funds to a Boston-based company to develop a portable rapid polymerase chain reaction (PCR) diagnostic to identify the presence of Neisseria gonorrhoeae, a pathogen that causes gonorrhea, and its susceptibility to ciprofloxacin.

Future Market Scenario (2024-2031F)

The phenotyping of AST using flow cytometry, isothermal microcalorimetry, and digital imaging is becoming increasingly popular. Compared to standard growth-based AST, which can take 18-24 hours, can yield findings typically in 1-2 hours.

Whole genome sequencing is a genomic technique that may quickly identify genetic markers linked to antibiotic resistance. It is being investigated for AST. When contrasted with culture-based approaches, this could enable faster turnaround times.

Integrated diagnostic tools that are capable of AST and microbiological identification are becoming more common. These systems are designed to streamline the testing process and deliver fast results through data that will help with antibiotic selection.

Various regions and organizations, including the European Commission, European Food Safety Authority, European Medicines Agency, and European Centre for Disease Prevention and Control, are working to standardize and unify advancements in fast antimicrobial susceptibility testing.

Key Players Landscape and Outlook

Several medical device companies are flourishing in the antimicrobial susceptibility testing market by planning and adopting new strategies. They are complying with new strategic initiatives for antimicrobial susceptibility testing devices to increase their market presence. New agreements, contracts, acquisitions, mergers, investments, and partnerships are major ways through which they are trying to achieve higher market share.

In April 2023, Biomeriux SA and JMI labs established a six-year partnership to work together on projects aimed at assessing the effectiveness and expanding the potential of rapid and innovative microbiological diagnostics as crucial instruments in the fight against antibiotic resistance.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Manual Antimicrobial Susceptibility Testing Product
    • 4.2.1.2. Automated Laboratory Instruments
    • 4.2.1.3. Culture and Growth Media
    • 4.2.1.4. Consumables
  • 4.2.2. By Type
    • 4.2.2.1. Antibacterial Susceptibility Testing
    • 4.2.2.2. Antifungal Susceptibility Testing
    • 4.2.2.3. Antiparasitic Susceptibility Testing
    • 4.2.2.4. Other Susceptibility Testing
  • 4.2.3. By Application
    • 4.2.3.1. Clinical Diagnostics
    • 4.2.3.2. Drug Discovery and Development
    • 4.2.3.3. Epidemiology
    • 4.2.3.4. Others
  • 4.2.4. By End-user
    • 4.2.4.1. Hospitals
    • 4.2.4.2. Diagnostic Centers
    • 4.2.4.3. Pharmaceutical and Biotechnology Companies
    • 4.2.4.4. Clinical Research Organizations
    • 4.2.4.5. Others
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia-Pacific
    • 4.2.5.4. South America
    • 4.2.5.5. Middle East and Africa
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Product
  • 4.3.2. By Type
  • 4.3.3. By Application
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. North America Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Manual Antimicrobial Susceptibility Testing Product
    • 5.2.1.2. Automated Laboratory Instruments
    • 5.2.1.3. Culture and Growth Media
    • 5.2.1.4. Consumables
  • 5.2.2. By Type
    • 5.2.2.1. Antibacterial Susceptibility Testing
    • 5.2.2.2. Antifungal Susceptibility Testing
    • 5.2.2.3. Antiparasitic Susceptibility Testing
    • 5.2.2.4. Other Susceptibility Testing
  • 5.2.3. By Application
    • 5.2.3.1. Clinical Diagnostics
    • 5.2.3.2. Drug Discovery and Development
    • 5.2.3.3. Epidemiology
    • 5.2.3.4. Others
  • 5.2.4. By End-user
    • 5.2.4.1. Hospitals
    • 5.2.4.2. Diagnostic Centers
    • 5.2.4.3. Pharmaceutical and Biotechnology Companies
    • 5.2.4.4. Clinical Research Organizations
    • 5.2.4.5. Others
  • 5.2.5. By Country Share
    • 5.2.5.1. United States
    • 5.2.5.2. Canada
    • 5.2.5.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
      • 5.3.1.1.2. By Volume
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Product
        • 5.3.1.2.1.1. Manual Antimicrobial Susceptibility Testing Product
        • 5.3.1.2.1.2. Automated Laboratory Instruments
        • 5.3.1.2.1.3. Culture and Growth Media
        • 5.3.1.2.1.4. Consumables
      • 5.3.1.2.2. By Type
        • 5.3.1.2.2.1. Antibacterial Susceptibility Testing
        • 5.3.1.2.2.2. Antifungal Susceptibility Testing
        • 5.3.1.2.2.3. Antiparasitic Susceptibility Testing
        • 5.3.1.2.2.4. Other Susceptibility Testing
      • 5.3.1.2.3. By Application
        • 5.3.1.2.3.1. Clinical Diagnostics
        • 5.3.1.2.3.2. Drug Discovery and Development
        • 5.3.1.2.3.3. Epidemiology
        • 5.3.1.2.3.4. Others
      • 5.3.1.2.4. By End-user
        • 5.3.1.2.4.1. Hospitals
        • 5.3.1.2.4.2. Diagnostic Centers
        • 5.3.1.2.4.3. Pharmaceutical and Biotechnology Companies
        • 5.3.1.2.4.4. Clinical Research Organizations
        • 5.3.1.2.4.5. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Turkey
• 6.9. Poland

7. Asia-Pacific Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Antimicrobial Susceptibility Testing Market Outlook, 2017-2031F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

• 16.1. Market Drivers
• 16.2. Market Challenges

17. Regulatory Framework and Innovation

• 17.1. Clinical Trials
• 17.2. Patent Landscape
• 17.3. Regulatory Approvals
• 17.4. Innovations/Emerging Technologies

18. Market Trends and Developments

19. Case Studies

20. Competitive Landscape

• 20.1. Competition Matrix of Top 5 Market Leaders
• 20.2. SWOT Analysis for Top 5 Players
• 20.3. Key Players Landscape for Top 10 Market Players
  • 20.3.1. Biomeriux SA
    • 20.3.1.1. Company Details
    • 20.3.1.2. Key Management Personnel
    • 20.3.1.3. Products and Services
    • 20.3.1.4. Financials (As Reported)
    • 20.3.1.5. Key Market Focus and Geographical Presence
    • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 20.3.2. Bio-Rad Laboratories Inc
  • 20.3.3. HiMedia Laboratories
  • 20.3.4. Alifax S.r.l Italy
  • 20.3.5. Becton Dickinson and Company
  • 20.3.6. Creative Diagnostics
  • 20.3.7. Resistell AG
  • 20.3.8. Danaher Corporation
  • 20.3.9. Thermo Fisher Scientific Inc
  • 20.3.10. Merck KGaA

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer